Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Quality improvement in neurology: Neuro-otology quality measurement set.

Rizk H, Agrawal Y, Barthel S, Bennett ML, Doherty JK, Gerend P, Gold DR, Morrill D, Oas JG, Roberts JK, Woodson E, Zapala DA, Bennett A, Shenoy AM.

Neurology. 2018 Oct 9;91(15):697-701. doi: 10.1212/WNL.0000000000006217. Epub 2018 Aug 31. No abstract available.

PMID:
30171079
2.

Quality Improvement in Neurology: Neurotology Quality Measurement Set.

Rizk H, Agrawal Y, Barthel S, Bennett ML, Doherty JK, Gerend P, Gold DR, Morrill D, Oas JG, Roberts JK, Woodson E, Zapala DA, Bennett A, Shenoy AM.

Otolaryngol Head Neck Surg. 2018 Oct;159(4):603-607. doi: 10.1177/0194599818790947. Epub 2018 Aug 31. No abstract available.

PMID:
30168353
3.

Cochlear implant histopathology.

Linthicum FH Jr, Doherty JK, Lopez IA, Ishiyama A.

World J Otorhinolaryngol Head Neck Surg. 2018 Mar 6;3(4):211-213. doi: 10.1016/j.wjorl.2017.12.008. eCollection 2017 Dec.

4.

Identification of target proteins involved in cochlear otosclerosis.

Richard C, Doherty JK, Fayad JN, Cordero A, Linthicum FH Jr.

Otol Neurotol. 2015 Jun;36(5):923-31. doi: 10.1097/MAO.0000000000000680.

5.

Short-term histopathology effects of gamma knife radiosurgery on a vestibular schwannoma.

Cassis A, Doherty JK, Daspit CP, Linthicum FH Jr.

Otolaryngol Head Neck Surg. 2013 Jun;148(6):1056-8. doi: 10.1177/0194599813478574. Epub 2013 Feb 20. No abstract available.

6.

Temporal bone histopathology case of the month: Modiolar dehiscence associated with sensorineural hearing loss.

Treadway JP, Doherty JK, Linthicum FH Jr.

Otol Neurotol. 2013 Jan;34(1):e4-5. doi: 10.1097/MAO.0b013e31826a544d. No abstract available.

7.

Temporal bone histopathology case of the month: Incidental discovery of a temporal bone chondroblastoma on an archived histopathologic section.

Richard C, Linthicum FH Jr, Doherty JK.

Otol Neurotol. 2013 Jul;34(5):e38-9. doi: 10.1097/MAO.0b013e318278bcdb. No abstract available.

8.

Adipose replacing intracochlear architecture after meningioma removal.

Doherty JK, Linthicum FH Jr.

Otol Neurotol. 2013 Feb;34(2):e8-9. doi: 10.1097/MAO.0b013e31826bf1d0. No abstract available.

9.

Activation of PDGFR and EGFR promotes the acquisition of a stem cell-like phenotype in schwannomas.

Yi D, Kuo SZ, Zheng H, Abhold EL, Brown CM, Doherty JK, Wang-Rodriguez J, Harris JP, Ongkeko WM.

Otol Neurotol. 2012 Dec;33(9):1640-7. doi: 10.1097/MAO.0b013e31826a540d.

PMID:
22935817
10.

ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.

Ahmad ZK, Brown CM, Cueva RA, Ryan AF, Doherty JK.

Otol Neurotol. 2011 Jul;32(5):841-7. doi: 10.1097/MAO.0b013e31821f7d88.

11.

Comparative case series of exostoses and osteomas of the internal auditory canal.

Baik FM, Nguyen L, Doherty JK, Harris JP, Mafee MF, Nguyen QT.

Ann Otol Rhinol Laryngol. 2011 Apr;120(4):255-60.

PMID:
21585156
12.

Exostoses and osteomas of the internal auditory canal.

Nguyen LT, Baik FM, Doherty JK, Harris JP, Nguyen QT.

Laryngoscope. 2010;120 Suppl 4:S215. doi: 10.1002/lary.21682. No abstract available.

PMID:
21225813
13.

EGF and bFGF promote invasion that is modulated by PI3/Akt kinase and Erk in vestibular schwannoma.

Blair KJ, Kiang A, Wang-Rodriguez J, Yu MA, Doherty JK, Ongkeko WM.

Otol Neurotol. 2011 Feb;32(2):308-14. doi: 10.1097/MAO.0b013e318206fc3d.

PMID:
21178801
14.

Potential role of imatinib mesylate (Gleevec, STI-571) in the treatment of vestibular schwannoma.

Altuna X, Lopez JP, Yu MA, Arandazi MJ, Harris JP, Wang-Rodriguez J, An Y, Dobrow R, Doherty JK, Ongkeko WM.

Otol Neurotol. 2011 Jan;32(1):163-70. doi: 10.1097/MAO.0b013e3182009665.

PMID:
21157293
15.

Estrogen receptor expression in sporadic vestibular schwannomas.

Brown CM, Ahmad ZK, Ryan AF, Doherty JK.

Otol Neurotol. 2011 Jan;32(1):158-62. doi: 10.1097/MAO.0b013e3181feb92a.

16.

Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.

Ahmad Z, Brown CM, Patel AK, Ryan AF, Ongkeko R, Doherty JK.

Otol Neurotol. 2010 Apr;31(3):460-6. doi: 10.1097/MAO.0b013e3181d2777f.

17.

Laterality of exostosis in surfers due to evaporative cooling effect.

King JF, Kinney AC, Iacobellis SF 2nd, Alexander TH, Harris JP, Torre P 3rd, Doherty JK, Nguyen QT.

Otol Neurotol. 2010 Feb;31(2):345-51. doi: 10.1097/MAO.0b013e3181be6b2d.

PMID:
19806064
18.

Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.

Fisher LM, Doherty JK, Lev MH, Slattery WH.

Otol Neurotol. 2009 Sep;30(6):835-41. doi: 10.1097/MAO.0b013e3181b2364c.

PMID:
19704365
19.

Cellular targeting for cochlear gene therapy.

Ryan AF, Mullen LM, Doherty JK.

Adv Otorhinolaryngol. 2009;66:99-115. doi: 10.1159/000218210. Epub 2009 Jun 2. Review.

20.

Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.

Patel AK, Alexander TH, Andalibi A, Ryan AF, Doherty JK.

Laryngoscope. 2008 Aug;118(8):1458-63. doi: 10.1097/MLG.0b013e318177e20b.

21.

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia.

Yevtushenko OO, Cooper SJ, O'Neill R, Doherty JK, Woodside JV, Reynolds GP.

Br J Psychiatry. 2008 Jun;192(6):424-8. doi: 10.1192/bjp.bp.107.041723.

PMID:
18515891
22.

ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy.

Doherty JK, Ongkeko W, Crawley B, Andalibi A, Ryan AF.

Otol Neurotol. 2008 Jan;29(1):50-7. doi: 10.1097/mao.0b013e31815d4429.

PMID:
18199957
23.

Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2.

Fisher LM, Doherty JK, Lev MH, Slattery WH 3rd.

Otol Neurotol. 2007 Dec;28(8):1083-90. Erratum in: Otol Neurotol. 2008 Sep;29(6):885.

PMID:
18043434
24.

Facial palsy and fallopian canal expansion associated with idiopathic intracranial hypertension.

Brackmann DE, Doherty JK.

Otol Neurotol. 2007 Aug;28(5):715-8.

PMID:
17667777
25.

CPA melanoma: diagnosis and management.

Brackmann DE, Doherty JK.

Otol Neurotol. 2007 Jun;28(4):529-37.

PMID:
17414177
26.

Endolymphatic sac tumor: a report of 3 cases and discussion of management.

Doherty JK, Yong M, Maceri D.

Ear Nose Throat J. 2007 Jan;86(1):30-5.

PMID:
17315832
27.

Controversies in building a management algorithm for vestibular schwannomas.

Doherty JK, Friedman RA.

Curr Opin Otolaryngol Head Neck Surg. 2006 Oct;14(5):305-13. Review.

PMID:
16974142
28.

Meniere's disease: prevalence of contralateral ear involvement.

House JW, Doherty JK, Fisher LM, Derebery MJ, Berliner KI.

Otol Neurotol. 2006 Apr;27(3):355-61.

PMID:
16639274
29.

Ossicular discontinuity and exostoses in Proteus syndrome: a case report.

Doherty JK, Maceri DR.

Ann Otol Rhinol Laryngol. 2005 Mar;114(3):242-6.

PMID:
15825577
30.

Cochlear endosteal erosion with focal osteomyelitis induced by cochlear implantation.

Doherty JK, Linthicum FH Jr.

Otol Neurotol. 2004 Nov;25(6):1029-30. No abstract available.

PMID:
15547439
31.

Spiral ligament and stria vascularis changes in cochlear otosclerosis: effect on hearing level.

Doherty JK, Linthicum FH Jr.

Otol Neurotol. 2004 Jul;25(4):457-64.

PMID:
15241221
32.

Pathology quiz case 2. Pemphigus vulgaris (PV).

Doherty JK, Lum C, Doherty C.

Arch Otolaryngol Head Neck Surg. 2003 Feb;129(2):254, 256-7. No abstract available.

PMID:
12578463
33.

Autologous fat grafting for the refractory patulous eustachian tube.

Doherty JK, Slattery WH 3rd.

Otolaryngol Head Neck Surg. 2003 Jan;128(1):88-91.

PMID:
12574764
34.
35.

The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor.

Doherty JK, Bond C, Jardim A, Adelman JP, Clinton GM.

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10869-74.

36.

An alternative HER-2/neu transcript of 8 kb has an extended 3'UTR and displays increased stability in SKOV-3 ovarian carcinoma cells.

Doherty JK, Bond CT, Hua W, Adelman JP, Clinton GM.

Gynecol Oncol. 1999 Sep;74(3):408-15.

PMID:
10479501
37.

NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.

Christianson TA, Doherty JK, Lin YJ, Ramsey EE, Holmes R, Keenan EJ, Clinton GM.

Cancer Res. 1998 Nov 15;58(22):5123-9.

38.

The development and training of a Russian distance runner.

DOHERTY JK.

J Sports Med Phys Fitness. 1962 Sep;2:164-70. No abstract available.

PMID:
14028384
39.

Nuclear and cytoplasmic organoids in the living cell.

DURYEE WR, DOHERTY JK.

Ann N Y Acad Sci. 1954 Nov 17;58(7):1210-31. No abstract available.

PMID:
14350513

Supplemental Content

Loading ...
Support Center